Modeling the 3q26 OncCassette using genetically engineered mice

被引：0
|
作者：
Meneses, Kayleah M.
Liu, Yi
Weems, Capella R.
Jamieson, Lee
Nguyen, Duy T.
Justilien, Verline
Murray, Nicole R.
Fields, Alan P.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-1434
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1434
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Unraveling the neurobiology of nicotine dependence using genetically engineered mice
    Stoker, Astrid K.
    Markou, Athina
    CURRENT OPINION IN NEUROBIOLOGY, 2013, 23 (04) : 493 - 499
  • [42] THE HUMAN THROMBOPOIETIN GENE IS LOCATED ON CHROMOSOME 3Q26.33-Q27, BUT IS NOT TRANSCRIPTIONALLY ACTIVATED IN LEUKEMIA-CELLS WITH 3Q21 AND 3Q26 ABNORMALITIES (3Q21Q26 SYNDROME)
    SUZUKAWA, K
    SATOH, H
    TANIWAKI, M
    YOKOTA, J
    MORISHITA, K
    LEUKEMIA, 1995, 9 (08) : 1328 - 1331
  • [43] Best Pathology Practices in Research Using Genetically Engineered Mice
    Bolon, B.
    Brayton, C.
    Cantor, G. H.
    Kusewitt, D. F.
    Loy, J. K.
    Sartin, E. A.
    Schoeb, T. R.
    Sellers, R. S.
    Schuh, J. C. L.
    Ward, J. M.
    VETERINARY PATHOLOGY, 2008, 45 (06) : 939 - 940
  • [44] Amplification of 3q26∼qter correlates with tumor progression in head and neck squamous cell carcinomas
    Hashimoto, Y
    Oga, A
    Kawauchi, S
    Furuya, T
    Shimizu, N
    Nakano, T
    Imate, Y
    Yamashita, H
    Sasaki, K
    CANCER GENETICS AND CYTOGENETICS, 2001, 129 (01) : 52 - 56
  • [45] SNO is a probable target for gene amplification at 3q26 in squamous-cell carcinomas of the esophagus
    Imoto, I
    Pimkhaokham, A
    Fukuda, Y
    Yang, ZQ
    Shimada, Y
    Nomura, N
    Hirai, H
    Imamura, M
    Inazawa, J
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 286 (03) : 559 - 565
  • [46] Molecular definition of a small amplification domain within 3q26 in tumors of cervix, ovary, and lung
    Sugita, M
    Tanaka, N
    Davidson, S
    Sekiya, S
    Varella-Garcia, M
    West, J
    Drabkin, HA
    Gemmill, RM
    CANCER GENETICS AND CYTOGENETICS, 2000, 117 (01) : 9 - 18
  • [47] Isolation of a novel candidate oncogene within a frequently amplified region at 3q26 in ovarian cancer
    Guan, XY
    Sham, JST
    Tang, TCM
    Fang, Y
    Huo, KK
    Yang, JM
    CANCER RESEARCH, 2001, 61 (09) : 3806 - 3809
  • [48] 3q26 amplification and polysomy of chromosome 3 in squamous cell lesions of the lung:: A fluorescence in situ hybridization study
    Pelosi, Giuseppe
    Del Curto, Barbara
    Trubia, Maurizio
    Nicholson, Andrew G.
    Manzotti, Michela
    Veronesi, Giulia
    Spaggiari, Lorenzo
    Maisonneuve, Patrick
    Pasini, Felice
    Terzi, Alberto
    Iannucci, Antonio
    Viale, Giuseppe
    CLINICAL CANCER RESEARCH, 2007, 13 (07) : 1995 - 2004
  • [49] Novel combination therapies against AML with 3q26 lesions and EVI1 overexpression
    Birdwell, Christine
    Fiskus, Warren C.
    Mill, Christopher P.
    Davis, John A.
    Jin, Qi
    DiNardo, Courtney D.
    Takahashi, Koichi
    Horrigan, Stephen
    Kadia, Tapan M.
    Daver, Naval
    Bhalla, Kapil N.
    CANCER RESEARCH, 2022, 82 (12)
  • [50] ABNORMALITIES OF 3Q21 AND 3Q26 IN MYELOID MALIGNANCY - A UNITED-KINGDOM CANCER CYTOGENETIC GROUP-STUDY
    SECKERWALKER, LM
    MEHTA, A
    BAIN, B
    BRITISH JOURNAL OF HAEMATOLOGY, 1995, 91 (02) : 490 - 501
12345